论文部分内容阅读
糖尿病肾病(Diabetic nephropathy,DN)是糖尿病最常见的慢性微血管并发症之一,应用前列尔注射液联合贝那普利治疗糖尿病肾病,尤其是难治性糖尿病肾病综合征取得较好的临床疗效,报告如下。1资料与方法1.1临床资料2010-2011年本院住院的2型DM并发临床DN的患者40例,诊断标准:糖尿病患者出现持续白蛋白>200μg/min或>300mg/24h,若伴有视网膜病变,临床及实验室检查排除其他肾脏或尿路疾病,可诊断为DN[1]。排除情况:血清肌酐>176.8μmol/L,血清钾浓度≥5.0mmol/L,其中男
Diabetic nephropathy (DN) is one of the most common chronic microvascular complication of diabetes mellitus, and the combination of Qianlie injection and benazepril in treating diabetic nephropathy, especially refractory diabetic nephrotic syndrome, has achieved good clinical efficacy, The report is as follows. 1 Materials and Methods 1.1 Clinical data 2010-2011 hospital type 2 DM clinical DN patients with 40 cases, diagnostic criteria: diabetes patients with persistent albumin> 200μg / min or> 300mg / 24h, if accompanied by retinopathy Clinical and laboratory tests to rule out other renal or urinary tract diseases can be diagnosed as DN [1]. Exclusion: serum creatinine> 176.8μmol / L, serum potassium concentration ≥ 5.0mmol / L, of which male